SK DISCOVERY CO., LTD. SK Discovery Co., Ltd. Stock Korea S.E.
Equities
A006125
KR7006121008
Oil & Gas Refining and Marketing
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32,100 KRW | +0.47% |
|
+3.55% | +4.90% |
| Sales 2022 | 8,717B 6.34B 8.66B | Sales 2023 | 8,939B 6.5B 8.88B | Capitalization | 758B 551M 752M |
|---|---|---|---|---|---|
| Net income 2022 | 427B 311M 424M | Net income 2023 | 191B 139M 190M | EV / Sales 2022 | 0.23 x |
| Net Debt 2022 | 1,452B 1.06B 1.44B | Net Debt 2023 | 2,190B 1.59B 2.17B | EV / Sales 2023 | 0.33 x |
| P/E ratio 2022 |
1.5
x | P/E ratio 2023 |
4.04
x | Employees | 48 |
| Yield 2022 |
5.62% | Yield 2023 |
4.34% | Free-Float | 44.1% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.47% | ||
| 1 week | +3.55% | ||
| Current month | +1.90% | ||
| 1 month | +1.10% | ||
| 3 months | +6.82% | ||
| 6 months | +9.93% | ||
| Current year | +4.90% |
1 week
30 800.00
32 150.00
1 month
29 500.0032 400.00
Current year
28 500.0033 250.00
1 year
27 100.0034 550.00
3 years
26 300.0051 200.00
5 years
9 850.0087 800.00
10 years
9 850.0087 800.00
| Managers | Title | Age | Since |
|---|---|---|---|
Cheol Kim
CEO | Chief Executive Officer | 62 | 18-03-07 |
Chan-Joong Park
CEO | Chief Executive Officer | 59 | 18-03-07 |
Chang-Won Chey
CEO | Chief Executive Officer | 59 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chang-Won Chey
CEO | Chief Executive Officer | 59 | - |
Jae-Yong Song
BRD | Director/Board Member | 60 | - |
Chan-Joong Park
CEO | Chief Executive Officer | 59 | 18-03-07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 32,100 | +0.47% | 3,286 |
| 24-04-25 | 31,950 | +0.16% | 3,731 |
| 24-04-24 | 31,900 | +0.95% | 3,316 |
| 24-04-23 | 31,600 | +0.16% | 1,568 |
| 24-04-22 | 31,550 | +1.77% | 2,896 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
SK Discovery Co Ltd, formerly SK Chemicals Co Ltd, is a Korea-based company mainly engaged in the manufacture and distribution of chemicals. The Company operates its business through three segments. The Gas segment is engaged in importing, storing and distributing liquefied petroleum gas (LPG). The Life Sciences segment manufactures and sells products such as blood circulation improvers, vaccines, and blood products. The Investment segment operates businesses such as subsidiaries management and new business investment.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -5.24% | 5.86B | |
| 0.00% | 4.55B | |
| -13.69% | 3.91B | |
| +44.27% | 3.57B | |
| -1.43% | 3.56B | |
| +23.40% | 3.23B | |
| +8.47% | 1.95B | |
| +11.60% | 1.6B | |
| +1.01% | 1.38B |
- Stock Market
- Equities
- A006120 Stock
- A006125 Stock
